ArticleFrontiers in neurology2026

Efgartigimod-alfa therapy in acetylcholine receptor antibody myasthenia gravis: Romanian experience.

Nicolae Grecu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.